Retension Pharmaceuticals, Inc. (RTSN) Stock
Retension Pharmaceuticals stock price chart
RTSN stock quote & key statistics
About Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.
Retension Pharmaceuticals stock FAQ
What is the Retension Pharmaceuticals stock ticker symbol?
Retension Pharmaceuticals, Inc. trades on the NASDAQ under the ticker symbol RTSN.
What sector and industry is Retension Pharmaceuticals in?
Retension Pharmaceuticals, Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Retension Pharmaceuticals have?
Retension Pharmaceuticals, Inc. has about 12 full-time employees.
When did Retension Pharmaceuticals go public?
Retension Pharmaceuticals stock began trading on October 9, 2026.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex